Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system.

Research output: Contribution to journal › Article › peer-review

Cite this

@article{f594a7b68cb1416b91ec7e1d6fa38a42,

title = "Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system.",

author = "Blacklock, {Jerry Bob} and Grimm, {E. A.}",

year = "1989",

month = jan,

day = "1",

language = "English (US)",

volume = "48",

pages = "93--99",

journal = "Immunology series",

issn = "0092-6019",

}

TY - JOUR

T1 - Lymphokine-activated killer lymphocytes

T2 - LAK and interleukin-2 in the treatment of malignancies of the central nervous system.

AU - Blacklock, Jerry Bob

AU - Grimm, E. A.

PY - 1989/1/1

Y1 - 1989/1/1

UR - http://www.scopus.com/inward/record.url?scp=0024893727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024893727&partnerID=8YFLogxK

M3 - Article

C2 - 2488328

AN - SCOPUS:0024893727

VL - 48

SP - 93

EP - 99

JO - Immunology series

JF - Immunology series

SN - 0092-6019

ER -